Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | N/A | -7,904 |
| Depreciation Amortization | N/A | 245 |
| Other Working Capital | N/A | 1,114 |
| Other Operating Activity | 0 | 1,058 |
| Operating Cash Flow | $N/A | $-5,487 |
| Cash Flows From Investing Activities | ||
| PPE Investments | N/A | -139 |
| Investing Cash Flow | $N/A | $-139 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 5,239 |
| Financing Cash Flow | $N/A | $5,239 |
| Exchange Rate Effect | N/A | -44 |
| Beginning Cash Position | N/A | 1,507 |
| End Cash Position | N/A | 1,076 |
| Net Cash Flow | $N/A | $-431 |
| Free Cash Flow | ||
| Operating Cash Flow | N/A | -5,487 |
| Free Cash Flow | 0 | -5,487 |